बिमाटोप्रोस्ट के इंटरैक्शन
हम जिन FDA लेबल और फैक्ट शीट को इंडेक्स करते हैं, उनमें बिमाटोप्रोस्ट (Lumigan, Latisse; प्रोस्टाग्लैंडिन एनालॉग) के 33 इंटरैक्शन दर्ज हैं: 3 गंभीर, 27 मध्यम, 3 मामूली, और 0 ऐसे जिनमें लेबल बताता है कि कोई महत्वपूर्ण इंटरैक्शन नहीं है। नीचे की हर प्रविष्टि उस वाक्य को उद्धृत करती है जिस पर वह आधारित है। दवा का यह पेज एक शुरुआती बिंदु है, आपकी स्थिति के लिए कोई फ़ैसला नहीं।
लेबल से लिए गए इंटरैक्शन
गंभीर इंटरैक्शन (3)
Ketorolac tromethamine is contraindicated in labor and delivery because, through its prostaglandin synthesis inhibitory effect, it may adversely affect fetal circulation and inhibit uterine contractions, thus increasing the risk of uterine hemorrhage. (कीटोरोलैक लेबल, निषेध (कॉन्ट्राइंडिकेशन))
…fatal, anaphylactic reactions to NSAIDs have been reported in such patients [see Warnings and Precautions (5.8 , 5.9) ] • Known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to diclofenac sodium and misoprostol, other prostaglandins, or any components of the drug product [see Warnings and Precautions (5.8 , 5.10) ] • Pregnancy ( 4 ) (डाइक्लोफेनाक और मिसोप्रोस्टोल लेबल, निषेध (कॉन्ट्राइंडिकेशन))
The combined use of two or more prostaglandins, or prostaglandin analogs including XELPROS is not recommended. (लैटानोप्रोस्ट लेबल, दवाओं के इंटरैक्शन)
मध्यम इंटरैक्शन (27)
Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (आइबुप्रोफेन लेबल, चेतावनियां और सावधानियां)
Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (आइबुप्रोफेन और फैमोटिडीन लेबल, चेतावनियां और सावधानियां)
Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (इंडोमेथासिन लेबल, चेतावनियां और सावधानियां)
Concomitant use of prostaglandin synthase inhibiting drugs, e.g., indomethacin, may decrease the hypotensive effects of beta-blockers. (एटेनोलोल लेबल, दवाओं के इंटरैक्शन)
Concomitant use of prostaglandin synthase inhibiting drugs, e.g., indomethacin, may decrease the hypotensive effects of beta-blockers. (एटेनोलोल और क्लोरथैलिडोन लेबल, दवाओं के इंटरैक्शन)
Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (एटोडोलैक लेबल, चेतावनियां)
Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (ऑक्साप्रोज़िन लेबल, चेतावनियां और सावधानियां)
A second form of renal toxicity has been seen in patients with conditions leading to a reduction in renal blood flow or blood volume, where renal prostaglandins have a supportive role in the maintenance of renal blood flow. (कीटोप्रोफेन लेबल, चेतावनियां और सावधानियां)
Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (टोल्मेटिन लेबल, चेतावनियां)
Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (डाइक्लोफेनाक लेबल, चेतावनियां और सावधानियां)
Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (डाइफ्लुनिसाल लेबल, चेतावनियां)
Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (नेप्रोक्सेन लेबल, चेतावनियां और सावधानियां)
Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (नेप्रोक्सेन और एसोमेप्राज़ोल लेबल, चेतावनियां और सावधानियां)
Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (नैबुमेटोन लेबल, चेतावनियां)
Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (पाइरोक्सिकैम लेबल, चेतावनियां और सावधानियां)
Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (पैरासिटामोल और आइबुप्रोफेन लेबल, चेतावनियां और सावधानियां)
Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (फेनोप्रोफेन लेबल, चेतावनियां और सावधानियां)
Indomethacin Coadministration of indomethacin may reduce the natriuretic and antihypertensive effects of furosemide in some patients by inhibiting prostaglandin synthesis. (फ्यूरोसेमाइड लेबल, दवाओं के इंटरैक्शन)
Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (फ्लर्बिप्रोफेन लेबल, चेतावनियां और सावधानियां)
Caution should be exercised when methylergonovine maleate is used concurrently with other vasoconstrictors, ergot alkaloids, or prostaglandins. (मिथाइलएर्गोमेट्रिन लेबल, दवाओं के इंटरैक्शन)
Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (मेफेनामिक एसिड लेबल, चेतावनियां और सावधानियां)
Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (मेलोक्सिकैम लेबल, चेतावनियां और सावधानियां)
Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (साल्सालेट लेबल, चेतावनियां)
Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (सुमाट्रिप्टान और नेप्रोक्सेन लेबल, चेतावनियां और सावधानियां)
Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion.In these patients, administration of a non-steroidal anti-inflammatory drug may cause a dose-dependent reduction in prostaglandin formation and, secondarily, in renal blood flow, which may precipitate overt renal decompensation. (सुलिंडैक लेबल, चेतावनियां)
Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (सेलेकॉक्सिब लेबल, चेतावनियां और सावधानियां)
Renal Toxicity and Hyperkalemia Renal Toxicity Long-term administration of NSAIDs has resulted in renal papillary necrosis and other renal injury.Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. (हाइड्रोकोडोन और आइबुप्रोफेन लेबल, चेतावनियां)
मामूली ज़िक्र (3)
Evidence from animal studies has suggested that certain other prostaglandins have some teratogenic potential. (कार्बोप्रोस्ट लेबल, चेतावनियां)
Bronchospasm Like other inhaled prostaglandins, Tyvaso may cause acute bronchospasm. (ट्रेप्रोस्टिनिल लेबल, चेतावनियां और सावधानियां)
Nonsteroidal Anti-inflammatory Drugs (NSAIDs) NSAIDs may produce potassium retention by reducing renal synthesis of prostaglandin E and impairing the renin-angiotensin system. (पोटैशियम क्लोराइड लेबल, दवाओं के इंटरैक्शन)
आप जो कुछ भी लेते हैं, उस सबके साथ बिमाटोप्रोस्ट को जांचें। अपनी पूरी सूची जोड़ें; हर जोड़ी एक साथ जांची जाती है।
चेकर में खोलेंयह चिकित्सकीय सलाह नहीं है। गंभीरता लेबल के शब्दों को दर्शाती है, आपकी परिस्थितियों को नहीं। “गंभीर” चिह्न वाला संयोजन डॉक्टर की देखरेख में सामान्य बात हो सकता है, और “मामूली” चिह्न वाला संयोजन ऊंची खुराक पर मायने रख सकता है। फार्मासिस्ट से पूछें।